Table 4. Market share by number of branded viral load (VL) technologies in 2011, 2012, and 2013 for all responding countries.
| VL Technology | WHO PQ Status | 2011 | 2012 | 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Reporting Countries | Number of Reported Instruments | Percentage from Total Number of Reported Instruments | Number of Reporting Countries | Number of Reported Instruments | Percentage from Total Number of Reported Instruments | Number of Reporting Countries | Number of Reported Instruments | Percentage from Total Number of Reported Instruments | ||
| Abbott m2000 | Yes | 27 | 104 | 18.5% | 32 | 191 | 27.8% | 35 | 255 | 29.3% |
| COBAS AmpliPrep/COBAS Taqman (48 or 96) | Yes | 29 | 99 | 17.6% | 35 | 155 | 22.6% | 40 | 250 | 28.7% |
| COBAS AMPLICOR Analyzer | No | 32 | 156 | 27.8% | 32 | 131 | 19.1% | 31 | 160 | 18.4% |
| NucliSENS EasyQ | Yes | 13 | 104 | 18.5% | 17 | 126 | 18.4% | 15 | 109 | 12.5% |
| VERSANT kPCR Molecular System | Yes | 8 | 41 | 7.3% | 9 | 52 | 7.6% | 8 | 42 | 4.8% |
| Other | N/A | 11 | 58 | 10.3% | 10 | 31 | 4.5% | 11 | 55 | 6.3% |